Cargando…

Atypical Infantile-onset Pompe Disease with Hypertrophic Cardiomyopathy

Detalles Bibliográficos
Autores principales:	Quan, Jun-Jun, Liu, Ling-Juan, Lyu, Tie-Wei, Huang, Xu-Pei, Tian, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634097/ https://www.ncbi.nlm.nih.gov/pubmed/28937052 http://dx.doi.org/10.4103/0366-6999.215340

Ejemplares similares

Blepharoptosis in infantile onset Pompe disease: Histological findings and surgical outcomes
por: Chen, Yi-Hua, et al.
Publicado: (2023)

Hypertrophy cardiomyopathy: A case of infantile-onset Pompe disease in cardiac magnetic resonance findings
por: Zhong, Yi, et al.
Publicado: (2023)

The Outcome of Infantile Onset Pompe Disease in South of Iran
por: Moravej, Hossein, et al.
Publicado: (2016)

The infantile-onset form of Pompe disease: an autopsy diagnosis
por: dos Santos, Otávio César Cruz, et al.
Publicado: (2015)

Atypical infantile-onset Pompe disease with good prognosis from mainland China: A case report
por: Zhang, Ying, et al.
Publicado: (2022)

Recommendations for Infantile-Onset and Late-Onset Pompe Disease: An Iranian Consensus
por: Fatehi, Farzad, et al.
Publicado: (2021)

The Timely Needs for Infantile Onset Pompe Disease Newborn Screening—Practice in Taiwan
por: Chiang, Shu-Chuan, et al.
Publicado: (2020)

S2.2 Enzyme replacement therapy in the infantile-onset Pompe disease
por: Parenti, Giancarlo, et al.
Publicado: (2011)

Infantile onset Pompe disease presenting with non-immune hydrops fetalis
por: Lee, Kristen, et al.
Publicado: (2019)

Adenotonsillectomy should be avoided whenever possible in infantile-onset Pompe disease
por: Jones, Harrison N., et al.
Publicado: (2020)

CRISPR-Cas9 generated Pompe knock-in murine model exhibits early-onset hypertrophic cardiomyopathy and skeletal muscle weakness
por: Huang, Jeffrey Y., et al.
Publicado: (2020)

Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy
por: Hsueh, Chien-Yu, et al.
Publicado: (2021)

Letter to the Editors: Concerning “Divergent clinical outcomes of alphaglucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state” by Takashi M et al.
por: Ortolano, Rita, et al.
Publicado: (2017)

Infantile‐onset Pompe disease with neutropenia: Treatment decisions in the face of a unique phenotype
por: Riedy, Mary, et al.
Publicado: (2022)

Unusual Evolution of Hypertrophic Cardiomyopathy in Non-Compaction Myocardium in a Pompe Disease Patient
por: Gragnaniello, Vincenza, et al.
Publicado: (2023)

The phenotype, genotype, and outcome of infantile-onset Pompe disease in 18 Saudi patients
por: Al-Hassnan, Zuhair N., et al.
Publicado: (2018)

Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease()
por: Chien, Yin-Hsiu, et al.
Publicado: (2017)

Infantile Pompe disease with intrauterine onset: a case report and literature review
por: Xi, Hongmin, et al.
Publicado: (2022)

Muscle ultrasound: A useful tool in newborn screening for infantile onset pompe disease
por: Hwang, Hsuen-En, et al.
Publicado: (2017)

Infantile-onset Pompe disease with neonatal debut: A case report and literature review
por: Martínez, Miriam, et al.
Publicado: (2017)

Clinical course, mutations and its functional characteristics of infantile-onset Pompe disease in Thailand
por: Ngiwsara, Lukana, et al.
Publicado: (2019)

New Variant With a Previously Unrecognized Mechanism of Pathogenicity in Hypertrophic Cardiomyopathy
por: Aguib, Yasmine, et al.
Publicado: (2021)

Letter to the Editors: Concerning “Divergent clinical outcomes of alpha-glucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state” by Takashi et al. and Letter to the Editors by Ortolano et al.
por: Schänzer, Anne, et al.
Publicado: (2017)

Hemorrhagic stroke caused by moyamoya disease in a patient with obstructive hypertrophic cardiomyopathy
por: Liu, Sheng, et al.
Publicado: (2021)

Infective endocarditis in obstructive hypertrophic cardiomyopathy: a case series and literature review
por: Wu, Zi-Wen, et al.
Publicado: (2021)

Atypical variants of takotsubo cardiomyopathy: mechanistic and clinical implications
por: Yalta, Kenan, et al.
Publicado: (2020)

Importance of Timely Treatment Initiation in Infantile-Onset Pompe Disease, a Single-Centre Experience
por: de las Heras, Javier, et al.
Publicado: (2021)

Non-specificity of symptoms in infantile-onset Pompe disease may delay the diagnosis and institution of treatment
por: Senarathne, Udara Dilrukshi, et al.
Publicado: (2022)

Infantile-onset Pompe disease complicated by sickle cell anemia: Case report and management considerations
por: Starosta, Rodrigo Tzovenos, et al.
Publicado: (2022)

Expert Group Consensus on early diagnosis and management of infantile-onset pompe disease in the Gulf Region
por: Al-Hassnan, Zuhair, et al.
Publicado: (2022)

Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group
por: Al Jasmi, Fatma, et al.
Publicado: (2015)

Nystagmus in infantile Pompe disease: a new feature?
por: Turco, Emanuela Claudia, et al.
Publicado: (2020)

A New Mutation Causing Severe Infantile-Onset Pompe Disease Responsive to Enzyme Replacement Therapy
por: Moravej, Hossein, et al.
Publicado: (2018)

A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS Cells
por: Yoshida, Takeshi, et al.
Publicado: (2017)

Correction: Expert Group Consensus on early diagnosis and management of infantile-onset pompe disease in the Gulf Region
por: Al-Hassnan, Zuhair, et al.
Publicado: (2023)

Are there sex differences following treatment of left ventricular outflow tract obstruction in adults with hypertrophic cardiomyopathy?
por: Chahal, Anwar A., et al.
Publicado: (2017)

Caseous mitral valve calcification and concurrent hypertrophic obstructive cardiomyopathy: A rare cause of stroke
por: Ullah, Waqas, et al.
Publicado: (2020)

Late onset of neutral lipid storage disease due to a rare PNPLA2 mutation in a patient with myopathy and cardiomyopathy
por: Tian, Ye, et al.
Publicado: (2022)

Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy
por: Parini, Rossella, et al.
Publicado: (2018)

A Liver Model of Infantile-Onset Pompe Disease Using Patient-Specific Induced Pluripotent Stem Cells
por: Yoshida, Takeshi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o3n25rhtd1v064vl34sbteis1r